Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis

  1. Cortes, J.
  2. Haiderali, A.
  3. Huang, M.
  4. Pan, W.
  5. Schmid, P.
  6. Akers, K.G.
  7. Park, J.E.
  8. Frederickson, A.M.
  9. Fasching, P.A.
  10. O’Shaughnessy, J.
Revista:
BMC Cancer

ISSN: 1471-2407

Ano de publicación: 2023

Volume: 23

Número: 1

Tipo: Artigo

DOI: 10.1186/S12885-023-11293-4 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus